Brain Neoplasms: Clinical Trials

858 trials for Brain Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

398 completed, 134 terminated, 103 recruiting, 92 unknown. 858 Phase 2, 195 Phase 1, 16 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2858Completed 398, Terminated 134, Recruiting 103, Unknown 92, Active not recruiting 58, Withdrawn 43, Not yet recruiting 23, Suspended 7
Phase 1195Completed 86, Terminated 32, Recruiting 30, Active not recruiting 17, Unknown 12, Withdrawn 10, Not yet recruiting 4, Suspended 4
Phase 316Completed 7, Unknown 5, Recruiting 2, Active not recruiting 1, Not yet recruiting 1

Follow Brain Neoplasms: new trials by email Literature Review of Brain Neoplasms trials Research Report on Brain Neoplasms

Trials (filtered) newest first · largest first

All 858 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma
JBI-778 - Brain Metastases From Solid Tumors, Leptomeningeal Disease
Phase 1 / Phase 2Not yet recruitingJubilant Therapeutics Inc.1132028-04-012026-08-07
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Aminolevulinic acid hydrochloride - Pediatric Brain Tumor
Phase 2Not yet recruitingCostas Hadjipanayis202027-08-012026-10-07
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
H3K27M-EIEs - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-10-30
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
Opdualag - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2Not yet recruitingNationwide Children's Hospital122027-03-012026-09-09
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Tovorafenib - High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV)
Phase 2Not yet recruitingNationwide Children's Hospital792027-02-012026-10-20
IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas
IDH1-vac, IS-vac, Temozolomide (TMZ) - Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4
Phase 2Not yet recruitingGerman Cancer Research Center2162027-02-012026-10-22
Ceritinib Treatment for Recurrent Meningiomas
Ceritinib - Recurrent Meningioma, Grade I and Grade II
Phase 2Not yet recruitingKevin Petrecca102027-01-012026-10-23
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera - Brain Tumor
Phase 1 / Phase 2RecruitingStanford University122026-12-012026-09-29
Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response
LSAM-Cisplatin - Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG)
Phase 1 / Phase 2Not yet recruitingNanOlogy, LLC202026-12-012026-08-18
CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery to Improve Treatment of Melanoma Brain Metastases
Emavusertib, Pembrolizumab, Stereotactic Radiosurgery - Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma
Phase 1 / Phase 2SuspendedMayo Clinic232026-11-302026-10-20
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
PEP-CMV vaccine, Tetanus booster, Nivolumab - Diffuse Midline Glioma, Diffuse Midline High-grade Glioma
Phase 1 / Phase 2SuspendedWashington University School of Medicine682026-11-302026-10-30
Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma
Alectinib, Entrectinib, Surgery - Infant-Type Hemispheric Glioma
Phase 2Not yet recruitingSt. Jude Children's Research Hospital502026-11-012026-11-04
Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery
Lemborexant 5 mg, placebo - Brain Neoplasms, Sleep Initiation and Maintenance Disorders
Phase 2Not yet recruitingBeijing Tiantan Hospital1122026-11-012026-10-29
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
BCB-276 - Diffuse Intrinsic Pontine Glioma, DIPG
Phase 2RecruitingBrainChild Bio, Inc752026-09-042026-10-28
Tarlatamab for SCLC Brain Metastases
Tarlatamab - Small Cell Lung Cancer, Brain Metastases, Adult
Phase 2RecruitingMaastricht University Medical Center352026-08-102026-11-12
Sac-TMT for Active TNBC Brain Metastases
Sacituzumab tirumotecan - Metastatic Triple Negative Breast Cancers
Phase 2Not yet recruitingYale University202026-08-012026-07-24
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Navlimetostat, Daraxonrasib, Temozolomide - Solid Tumors
Phase 2RecruitingBristol-Myers Squibb2542026-07-272026-11-04
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
LMP744, Conventional Surgery or Biopsy - Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Phase 1 / Phase 2RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)402026-07-152026-10-16
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Valganciclovir - Brain Cancer Metastatic, CMV Viremia
Phase 2RecruitingThe Methodist Hospital Research Institute282026-07-142026-08-10
Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
Pre-radiation temozolomide. - High Grade Gliomas, Glioblastoma
Phase 2RecruitingThe Cooper Health System702026-07-132026-10-09

Showing 20 of 858. Sign in to see all of them.

Narrower conditions

Glioblastoma (291)  ·  Glioma (192)  ·  Gliosarcoma (154)  ·  Central Nervous System Neoplasms (146)  ·  Astrocytoma (141)  ·  Oligodendroglioma (102)  ·  Carcinoma, Non-Small-Cell Lung (91)  ·  Breast Neoplasms (75)  ·  Neoplasm Metastasis (62)  ·  Melanoma (61)  ·  Neoplasms (53)  ·  Lung Neoplasms (50)  ·  Diffuse Intrinsic Pontine Glioma (44)  ·  Ependymoma (41)

Broader conditions

Nervous System Neoplasms (854)  ·  Nervous System Diseases (853)  ·  Neoplasms by Site (852)  ·  Brain Diseases (851)  ·  Central Nervous System Diseases (849)  ·  Neoplasms (805)  ·  Central Nervous System Neoplasms (712)  ·  Neoplasms by Histologic Type (504)  ·  Neoplasms, Nerve Tissue (482)  ·  Neuroectodermal Tumors (471)  ·  Neoplasms, Germ Cell and Embryonal (466)  ·  Neoplasms, Glandular and Epithelial (437)  ·  Neoplasms, Neuroepithelial (411)  ·  Glioma (215)  ·  Astrocytoma (178)

Interventions

Temozolomide (116)  ·  Bevacizumab (78)  ·  Radiotherapy (57)  ·  Carboplatin (41)  ·  Radiosurgery (41)  ·  Irinotecan (26)  ·  pembrolizumab (25)  ·  Cisplatin (23)  ·  Erlotinib Hydrochloride (23)  ·  Cyclophosphamide (22)  ·  Etoposide (21)  ·  Nivolumab (21)  ·  Ipilimumab (19)  ·  Carmustine (16)  ·  Capecitabine (15)

Sponsors

National Cancer Institute (NCI) (67)  ·  M.D. Anderson Cancer Center (36)  ·  Duke University (35)  ·  Memorial Sloan Kettering Cancer Center (16)  ·  Novartis Pharmaceuticals (13)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (12)  ·  Fudan University (11)  ·  Sun Yat-sen University (10)  ·  Case Comprehensive Cancer Center (9)  ·  Children's Oncology Group (9)  ·  New Approaches to Brain Tumor Therapy Consortium (9)  ·  St. Jude Children's Research Hospital (9)  ·  Wake Forest University Health Sciences (9)  ·  Alliance for Clinical Trials in Oncology (8)  ·  European Organisation for Research and Treatment of Cancer - EORTC (6)

Countries

United States (573)  ·  China (73)  ·  Canada (72)  ·  France (60)  ·  Spain (46)  ·  Germany (43)  ·  Australia (42)  ·  Italy (41)  ·  United Kingdom (33)  ·  Netherlands (31)  ·  Switzerland (26)  ·  Belgium (25)  ·  South Korea (20)  ·  Taiwan (16)  ·  Austria (14)

Top investigators

Henry S. Friedman, MD (9)  ·  David A. Reardon, MD (7)  ·  David Peereboom, MD (5)  ·  Stanislaw R. Burzynski, MD, PhD (5)  ·  Betty Lawrence (4)  ·  Edward G. Shaw, MD (4)  ·  Evanthia Galanis (4)  ·  Jeffrey Raizer, MD (4)  ·  Kevin A Camphausen, M.D. (4)  ·  Lauren E. Abrey, MD (4)  ·  Patrick Wen, MD (4)

Results publications

PMID 21865400, PMID 25098701, PMID 25303679, PMID 25789053, PMID 26148750, PMID 28592387, PMID 30670498, PMID 31587882, PMID 31838007, PMID 33067126, PMID 34081125, PMID 39024777, PMID 40086048, PMID 10655437, PMID 11452123, PMID 11772431, PMID 11907388, PMID 11937316, PMID 12177103, PMID 12434281, PMID 12749708, PMID 12750523, PMID 1408229, PMID 14506149, PMID 14586216, PMID 14625709, PMID 14670747, PMID 14769136, PMID 14769138, PMID 14769140, PMID 15073861, PMID 15292713, PMID 15514370, PMID 15758009, PMID 15809479, PMID 16011702, PMID 16012795, PMID 16034522, PMID 16078267, PMID 16133802, PMID 16170172, PMID 16265674, PMID 16314647, PMID 16510333, PMID 16533878, PMID 16549835, PMID 16598416, PMID 16645718, PMID 16648043, PMID 16757720

NIH funding

2023 (9), U01CA062399 (9), 2014 (7), 2015 (7), U01CA137443 (6), U10CA025224 (6), 2009 (5), 2018 (5), U10CA021661 (5), 2017 (4), 2019 (4), P30CA033572 (4), U01CA062475 (4), 2008 (3), 2025 (3)